Prostate Cancer - Results from #27840

Prostate-specific antigen velocity before and after elimination of factors that can confound the prostate-specific antigen level - Abstract June 27, 2011

Primary Gleason grade 4 impact on biochemical recurrence after permanent interstitial brachytherapy in Japanese patients with low- or intermediate-risk prostate cancer - Abstract June 27, 2011

Impact of hypoxia on the metastatic potential of human prostate cancer cells - Abstract June 27, 2011

Body composition, physical fitness, functional performance, quality of life, and fatigue benefits of exercise for prostate cancer patients: A systematic review - Abstract June 27, 2011

Mindfulness groups for men with advanced prostate cancer: A pilot study to assess feasibility and effectiveness and the role of peer support - Abstract June 27, 2011

The effect of marital status on stage and survival of prostate cancer patients treated with radical prostatectomy: A population-based study - Abstract June 27, 2011

Continued benefit to androgen deprivation therapy for prostate cancer patients treated with dose-escalated radiation therapy across multiple definitions of high-risk disease - Abstract June 27, 2011

Comparative evaluation of radiation treatments for clinically localized prostate cancer: An updated systematic review - Abstract June 27, 2011

Long-term disease stabilization by docetaxel plus estramustine for castration-resistant prostate cancer : Report of a case - Abstract June 27, 2011

Editor's Commentary - Long-term risk of clinical progression after biochemical recurrence following radical prostatectomy: The impact of time from surgery to recurrence June 27, 2011

Editor's Commentary - Salvage radiation in men after prostate-specific antigen failure and the risk of death June 27, 2011

How to select the best candidates for prostate biopsies? The role of traditional tools and contribution of new biomarkers in prostate cancer - Abstract June 26, 2011

Broadening horizons in medical management of prostate cancer - Abstract June 24, 2011

Prostate cancer from the horizon of the patient - Abstract June 24, 2011

News and perspective in management of high-risk prostate cancer - Abstract June 24, 2011

Phase II study of abiraterone acetate in chemotherapy-naive metastatic castration-resistant prostate cancer displaying bone flare discordant with serologic response - Abstract June 24, 2011

Feasibility and safety of silicone rubber contrast-enhanced microcomputed tomography in evaluating the angioarchitecture of prostatectomy specimens - Abstract June 24, 2011

Characterizing genetic risk at known prostate cancer susceptibility loci in African Americans - Abstract June 24, 2011

Persistently elevated prostate-specific antigen at six weeks after radical prostatectomy helps in early identification of patients who are likely to recur - Abstract June 24, 2011

High occurrence of aberrant lymph node spread on magnetic resonance lymphography in prostate cancer patients with a biochemical recurrence after radical prostatectomy - Abstract June 24, 2011

Page 1393 of 1447